CRCCE (01786) · Company profile · Eqvero

CRCCE

01786HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	3.41 bn CNY	3.1 bn CNY	3.09 bn CNY	2.81 bn CNY	2.16 bn CNY
Cost of revenue	2.71 bn CNY	2.4 bn CNY	2.55 bn CNY	2.04 bn CNY	1.53 bn CNY
Research and development expense	212.18 m CNY	237.96 m CNY	358.95 m CNY	261.05 m CNY	180.15 m CNY
Selling, general and administrative expense	247.48 m CNY	290.24 m CNY	363.72 m CNY	316.12 m CNY	291.5 m CNY
Operating profit after depreciation	122.28 m CNY	99.88 m CNY	-298.04 m CNY	147.37 m CNY	40.15 m CNY
Operating profit before depreciation	255.6 m CNY	230.97 m CNY	-150.44 m CNY	271.03 m CNY	157.41 m CNY
EBIT	122.28 m CNY	99.88 m CNY	-298.04 m CNY	147.37 m CNY	40.15 m CNY
EBITDA	255.6 m CNY	230.97 m CNY	-150.44 m CNY	271.03 m CNY	157.41 m CNY
Interest expense	386 k CNY	524 k CNY	673 k CNY	—	—
Profit before tax	150.85 m CNY	140.51 m CNY	137.09 m CNY	123.67 m CNY	44.55 m CNY
Income tax expense	6.78 m CNY	11.66 m CNY	-8.05 m CNY	7.99 m CNY	-5.83 m CNY
Income before extraordinary items	143.89 m CNY	128.21 m CNY	145.04 m CNY	115.67 m CNY	50.38 m CNY
Common dividends	44.08 m CNY	42.56 m CNY	45.6 m CNY	38 m CNY	15.2 m CNY
Total dividends	44.08 m CNY	42.56 m CNY	45.6 m CNY	38 m CNY	15.2 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.